Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Acute abdomen in a patient with homozygous type I hereditary angioedema: rapid improvement in computed tomography scans after C1 inhibitor replacement.
Jáuregui Presa I, Varona Peinador M, Pérez Bea M, Ruiz-Ogarrio MC, Gamboa Setién PM, García Lirio E, Soriano Galarraga AM, Antépara Ercoreca I, Ortiz de Zárate MM. Jáuregui Presa I, et al. J Investig Allergol Clin Immunol. 2013;23(7):504-6. J Investig Allergol Clin Immunol. 2013. PMID: 24654315 Free article. No abstract available.
Phase I study of subcutaneous allergen immunotherapy with Dermatophagoides pteronyssinus in patients with allergic rhinoconjunctivitis with or without asthma.
Hernández Fernández de Rojas D, Antépara Ercoreca I, Ponte Tellechea A, Ibáñez Echevarría E, Jáuregui Presa I, Gamboa Setién P, Asturias JA, Landeta Manzano A, Madariaga Goirigolzarri B. Hernández Fernández de Rojas D, et al. Among authors: jauregui presa i. Immunotherapy. 2015;7(2):89-99. doi: 10.2217/imt.15.13. Epub 2015 Feb 6. Immunotherapy. 2015. PMID: 25659029 Clinical Trial.
Etoricoxib-induced fixed drug eruption: Report of seven cases.
Martínez Antón MD, Galán Gimeno C, Sánchez de Vicente J, Jáuregui Presa I, Gamboa Setién PM. Martínez Antón MD, et al. Among authors: jauregui presa i. Contact Dermatitis. 2021 Mar;84(3):192-195. doi: 10.1111/cod.13659. Epub 2020 Aug 18. Contact Dermatitis. 2021. PMID: 32666601
Therapeutic Strategy According to Differences in Response to Omalizumab in Patients With Chronic Spontaneous Urticaria.
Giménez Arnau AM, Valero Santiago A, Bartra Tomás J, Jáuregui Presa I, Labrador Horrillo M, Miquel Miquel FJ, Ortiz de Frutos J, Sastre J, Silvestre Salvador JF, Ferrer Puga M. Giménez Arnau AM, et al. Among authors: jauregui presa i. J Investig Allergol Clin Immunol. 2019;29(5):338-348. doi: 10.18176/jiaci.0323. Epub 2018 Sep 17. J Investig Allergol Clin Immunol. 2019. PMID: 30222111 Free article. Review.
Daily Clinical Practice in the Management of Chronic Urticaria in Spain: Results of the UCREX Study.
Ferrer Puga M, Silvestre Salvador JF, Bartra Tomas J, Giménez-Arnau A, Labrador-Horrillo M, Miquel-Miquel J, Ortiz de Frutos FJ, Sastre Dominguez J, Valero Santiago A, Terradas-Montana P, Vidal-Jorge M, Jáuregui Presa I. Ferrer Puga M, et al. Among authors: jauregui presa i. Actas Dermosifiliogr. 2022 Jan;113(1):4-14. doi: 10.1016/j.ad.2021.06.014. Epub 2022 Feb 3. Actas Dermosifiliogr. 2022. PMID: 35244542 Free article. English, Spanish.
Daily Clinical Practice in the Management of Chronic Urticaria in Spain: Results of the UCREX Study.
Ferrer Puga M, Silvestre Salvador JF, Bartra Tomas J, Giménez-Arnau A, Labrador-Horrillo M, Miquel-Miquel J, Ortiz de Frutos FJ, Sastre Dominguez J, Valero Santiago A, Terradas-Montana P, Vidal-Jorge M, Jáuregui Presa I. Ferrer Puga M, et al. Among authors: jauregui presa i. Actas Dermosifiliogr. 2022 Jan;113(1):T4-T14. doi: 10.1016/j.ad.2021.06.007. Epub 2021 Jul 20. Actas Dermosifiliogr. 2022. PMID: 35249717 Free article. English, Spanish.
Treatment of moderate-to-severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series.
Armario-Hita JC, Pereyra-Rodriguez J, Silvestre JF, Ruiz-Villaverde R, Valero A, Izu-Belloso R, Jáuregui-Presa I, Curto-Barredo L, Figueras-Nart I, Herranz-Pinto P, Herraez-Herrera L, Ortiz-de-Frutos FJ, Martinez-Pilar L, Sastre J, Serra-Baldrich E. Armario-Hita JC, et al. Among authors: jauregui presa i. Br J Dermatol. 2019 Nov;181(5):1072-1074. doi: 10.1111/bjd.18041. Epub 2019 Jul 25. Br J Dermatol. 2019. PMID: 31021399 No abstract available.
Fundamental Aspects and Relevance of Components in Antihistamine Eye Drops.
Herrero-Vanrell R, Jáuregui Presa I, Leceta Bilbao A, Montero-Iruzubieta J. Herrero-Vanrell R, et al. Among authors: jauregui presa i. J Investig Allergol Clin Immunol. 2023 Dec;33(6):431-438. doi: 10.18176/jiaci.0963. J Investig Allergol Clin Immunol. 2023. PMID: 38095492 Free article. Review.
ALERGODATA: Sentinel Registry of Health Outcomes in Allergic Patients Treated With Biological Therapies at Specialized Allergology Clinics in Spain.
Antolín Amérigo D, Colás C, Dávila I, Del Cuvillo A, Delgado Romero J, Domínguez-Ortega J, Jáuregui Presa I, Lázaro Sastre M, Montoro Lacomba J, Sala-Cunill A, Sanchez-Garcia S, Veleiro Pérez B, Vidal C, Valero Santiago AL. Antolín Amérigo D, et al. Among authors: jauregui presa i. J Investig Allergol Clin Immunol. 2023 Dec 14;33(6):479-482. doi: 10.18176/jiaci.0908. Epub 2023 May 15. J Investig Allergol Clin Immunol. 2023. PMID: 37183958 Free article. No abstract available.
13 results